The current state of the healthcare system has changed dramatically in just 2 months, shifting resources to respond to COVID-19 and delaying some clinical trials, partnerships and investment. But medical device companies have responded by modifying existing technologies to help patients and clinicians impacted by the pandemic, and others have found ways to meet virtually with doctors, regulators and university tech transfer offices.
Join our panel, a partnership between LaunchBio and the North Carolina Biotechnology Center, to hear from CEOs of medical device startups on how they are leading their teams now and what they are planning for the eventual easing of restrictions across the country. The discussion will include insights into the impact of telemedicine on the industry, and what hospitals, insurers and investors are prioritizing for innovation and patient care.
Allison London Brown, CEO, UVision 360
Sherif Gabriel PhD, CEO BioMedInnovations LLC
Rita King, MBA, CEO and Senior Regulatory Consultant, Methodsense
Mark Your Calendars